AMRX — AMNEAL PHARMACEUTICALS INC
As of Q2 2026, 35 SEC-registered investment managers reported holding AMRX (AMNEAL PHARMACEUTICALS INC) in their latest 13F filings, with a combined reported value of $1.01B across 58.30M shares. That is +4.8% by share count (+2.66M shares) versus the previous quarter, while reported value moved +45.8%. Ownership is concentrated: the five largest holders account for 72.9% of reported value and the top ten for 85.3%.
Compared with the prior quarter, 2 opened new positions, 18 added to existing stakes, 15 trimmed, 4 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.
AMRX is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| BlackRock Inc history | Q2 2026 | 26.56M | $459.79M | 0.01% | Add |
| Vanguard Group history | Q4 2025 | 17.91M | $225.64M | 0.00% | Hold |
| Geode Capital Management history | Q2 2026 | 5.14M | $88.98M | 0.01% | Add |
| Morgan Stanley history | Q2 2026 | 4.11M | $71.14M | 0.00% | Reduce |
| Invesco Ltd history | Q2 2026 | 3.50M | $60.62M | 0.01% | Add |
| Goldman Sachs Group history | Q2 2026 | 3.01M | $52.17M | 0.01% | Add |
| Charles Schwab Investment Management history | Q2 2026 | 2.15M | $37.17M | 0.01% | Reduce |
| Northern Trust Corp history | Q2 2026 | 1.91M | $33.15M | 0.00% | Add |
| Citadel Advisors history | Q2 2026 | 1.15M | $19.87M | 0.00% | Add |
| BNY Mellon history | Q2 2026 | 1.02M | $17.57M | 0.00% | Add |
| Principal Global Investors history | Q2 2026 | 991.82K | $17.17M | 0.01% | Add |
| Fidelity Management & Research (FMR) history | Q2 2026 | 825.12K | $14.28M | 0.00% | Add |
| JPMorgan Chase & Co history | Q2 2026 | 795.00K | $13.85M | 0.00% | New |
| Bank of America Corp history | Q2 2026 | 795.54K | $13.77M | 0.00% | Add |
| AQR Capital Management history | Q2 2026 | 795.03K | $13.76M | 0.01% | Reduce |
| D. E. Shaw & Co history | Q2 2026 | 774.05K | $13.40M | 0.01% | Reduce |
| PSP Investments history | Q2 2026 | 591.84K | $10.24M | 0.03% | Reduce |
| UBS Group AG history | Q2 2026 | 444.40K | $7.69M | 0.00% | Reduce |
| Balyasny Asset Management history | Q2 2026 | 434.13K | $7.51M | 0.01% | Add |
| Wells Fargo & Co history | Q2 2026 | 422.39K | $7.31M | 0.00% | Add |
New Positions (Q2 2026)
- JPMorgan Chase & Co 795.00K sh · $13.85M
- Amundi US 39.89K sh · $690.50K
Fully Exited (vs previous quarter)
- MFS Investment Management sold 127.09K sh · $1.58M
- Point72 Asset Management sold 78.11K sh · $970.85K
- Janus Henderson Group sold 76.22K sh · $946.98K
- CPP Investments sold 35.40K sh · $440.02K
Fund Position History — shares by quarter (top 20 funds)
| Fund | Q3 2021 | Q4 2021 | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BlackRock Inc | — | — | — | — | — | — | — | — | — | — | — | — | 12.41M | 12.59M | 12.59M | 12.13M | 14.07M | 14.30M | 24.52M | 26.56M |
| Geode Capital Management | 1.62M | 1.76M | 1.71M | 1.73M | 1.78M | 1.83M | 1.88M | 2.19M | 2.32M | 2.44M | 2.77M | 3.41M | 3.79M | 3.81M | 3.83M | 3.76M | 4.03M | 3.99M | 4.55M | 5.14M |
| Morgan Stanley | 314.38K | 414.08K | 422.73K | 462.42K | 407.51K | 4.22M | 382.49K | 435.52K | 376.18K | 442.29K | 955.96K | 1.04M | 1.25M | 1.49M | 1.62M | 2.50M | 3.50M | 4.82M | 4.64M | 4.11M |
| Invesco Ltd | 203.12K | 193.71K | 209.93K | 264.99K | 248.52K | 408.84K | 409.35K | 392.31K | 417.88K | 1.47M | 1.25M | 1.18M | 2.30M | 1.91M | 2.27M | 1.17M | 1.69M | 1.75M | 3.19M | 3.50M |
| Goldman Sachs Group | 940.63K | 983.80K | 784.08K | 748.65K | 614.38K | 666.37K | 600.40K | 618.17K | 1.11M | 337.27K | 692.49K | 1.38M | 853.80K | 973.75K | 937.19K | 2.24M | 2.46M | 2.58M | 2.86M | 3.01M |
| Charles Schwab Investment Management | 1.15M | 1.16M | 1.18M | 1.17M | 1.19M | 1.20M | 1.16M | 1.26M | 1.30M | 1.33M | 1.23M | 1.20M | 1.40M | 1.54M | 1.77M | 1.82M | 2.08M | 2.14M | 2.18M | 2.15M |
| Northern Trust Corp | 1.15M | 1.10M | 1.03M | 1.05M | 1.04M | 1.03M | 1.03M | 1.19M | 1.21M | 1.32M | 1.27M | 1.25M | 1.62M | 1.78M | 1.71M | 1.61M | 1.63M | 1.55M | 1.71M | 1.91M |
| Citadel Advisors | 1.24M | 1.70M | 1.57M | 1.49M | 1.70M | 726.85K | 1.06M | 1.21M | 2.70M | 6.52M | 5.08M | 10.00M | 8.90M | 9.04M | 7.60M | 5.74M | 5.75M | 6.18M | 619.42K | 1.15M |
| BNY Mellon | 584.84K | 560.24K | 566.34K | 539.33K | 587.86K | 487.36K | 463.20K | 628.34K | 688.36K | 635.51K | 622.63K | 751.40K | 624.73K | 623.84K | 598.39K | 592.82K | 600.20K | 495.85K | 914.09K | 1.02M |
| Principal Global Investors | 198.11K | 138.04K | 103.57K | 92.10K | 53.89K | 70.23K | 61.37K | 49.34K | 54.43K | 50.41K | 110.08K | 93.57K | 88.62K | 96.83K | 97.71K | 109.06K | 108.44K | 154.88K | 972.53K | 991.82K |
| Fidelity Management & Research (FMR) | — | — | 124.25K | 124.25K | 122.83K | 123.49K | 121.43K | 121.99K | 155.61K | 149.69K | 149.43K | 161.63K | 203.51K | 272.68K | 304.00K | 263.69K | 293.57K | 377.02K | 792.01K | 825.12K |
| JPMorgan Chase & Co | 374.67K | 362.53K | 363.38K | 374.40K | 368.96K | 307.04K | 236.44K | 532.53K | 586.76K | 186.04K | 422.12K | 519.53K | 1.30M | 1.21M | 1.09M | 1.33M | 771.21K | 662.65K | — | 795.00K |
| Bank of America Corp | 40.83K | 62.96K | 33.18K | 69.98K | 69.90K | 943.59K | 125.99K | 110.02K | 258.61K | 182.03K | 221.34K | 536.06K | 174.66K | 556.88K | 537.35K | 544.89K | 662.89K | 451.16K | 676.79K | 795.54K |
| AQR Capital Management | — | — | 237.00K | 292.34K | 972.16K | 2.14M | 3.01M | 2.16M | 939.65K | 828.75K | 756.39K | 435.08K | 303.25K | 336.80K | 745.48K | 1.02M | 1.01M | 1.05M | 864.79K | 795.03K |
| D. E. Shaw & Co | 18.04K | 158.02K | 254.00K | 188.93K | 260.85K | 688.84K | 630.11K | 622.23K | 874.92K | 666.04K | 226.20K | 89.89K | — | — | 15.84K | 923.64K | 1.57M | 2.66M | 1.72M | 774.05K |
| PSP Investments | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 607.34K | 591.84K |
| UBS Group AG | 11.00K | 37.32K | 12.34K | 11.14K | 26.57K | 18.98K | 5.25K | 11.89K | 68.42K | 174.23K | 178.16K | 21.85M | 21.77M | 1.67M | 1.81M | 1.58M | 1.45M | 935.48K | 840.96K | 444.40K |
| Balyasny Asset Management | — | — | — | — | — | — | — | — | 29.59K | — | — | — | — | 172.31K | 719.08K | 199.99K | 646.19K | 689.87K | 79.12K | 434.13K |
| Wells Fargo & Co | 754.69K | 387.90K | 236.80K | 14.98K | 13.86K | 1.21K | 22.09K | 56.51K | 31.24K | 38.12K | 48.48K | 59.34K | 177.84K | 77.97K | 79.72K | 80.72K | 95.92K | 172.68K | 105.12K | 422.39K |
| Franklin Resources | — | — | — | — | — | — | — | — | 75.96K | 75.84K | 75.84K | 85.71K | 89.89K | 89.89K | 89.89K | 89.89K | 94.01K | 414.54K | 437.83K | 398.19K |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details